Clinical

AI can predict premature death among people with inflammatory bowel disease: study
A new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's and colitis.
Anti-overdose naloxone kits at transit stops could help save lives, study suggests
The study, published in the Canadian Medical Association Journal on March 17, found that naloxone kits placed at public transit locations had the ‘greatest coverage’ and efficiency for potentially reversing drug overdoses.

U.S. approved Alzheimer’s drug appears to be less effective in women

Clinicians should discuss risks vs benefits of lecanemab in female patients.
A painless patch? A potential new option for diabetes monitoring

Researchers at the University of Waterloo are close to commercializing these next-generation monitoring tool.
Agility, access, aluminium: CPhA webinar hashes out tariffs and their impact for pharmacists

Speakers included McKesson's Anthony Leong, Health Minister Kamal Khera and CPhA's Joelle Walker.
QUIZ: Behavioural and psychological symptoms of dementia

Your dementia patients may be suffering from agitation, depression and related symptoms. Test your knowledge of the latest treatment advice from the Canadian Coalition for Seniors’ Mental Health (CCSMH).
Sitting in the light

As part of a series of first-person true stories written by physicians, Dr. Kristina Powles reflects on the moments after a patient has given birth.
Researchers find a hint at how to delay Alzheimer’s symptoms. Now they have to prove it

Two drugs sold in the U.S. can modestly slow worsening of early-stage Alzheimer’s by clearing the brain of one of its hallmarks, a sticky gunk called amyloid. But until now, there haven’t been hints that removing amyloid far earlier—many years before the first symptoms appear—just might postpone the disease.
Ontario sees another sharp rise in measles cases while outbreaks grow in Quebec, Alberta

Public Health Ontario is reporting 470 measles cases since an outbreak began in October. That’s an increase of 120 cases since March 14.
Could an Ozempic-like medication soon be just another plant grown in your garden?

Students at the University of Ottawa launch biomanufacturing platform to produce diabetes drugs.

AI can predict premature death among people with inflammatory bowel disease: study

Anti-overdose naloxone kits at transit stops could help save lives, study suggests

U.S. approved Alzheimer’s drug appears to be less effective in women

A painless patch? A potential new option for diabetes monitoring

Agility, access, aluminium: CPhA webinar hashes out tariffs and their impact for pharmacists

QUIZ: Behavioural and psychological symptoms of dementia

Sitting in the light

Researchers find a hint at how to delay Alzheimer’s symptoms. Now they have to prove it

Ontario sees another sharp rise in measles cases while outbreaks grow in Quebec, Alberta

Could an Ozempic-like medication soon be just another plant grown in your garden?

Related Topics